All Physicians In Switzerland Are Now Able To Prescribe Sucampo Pharmaceuticals, Inc. (SCMP)'s AMITIZA® For Chronic Idiopathic Constipation
2/6/2014 9:32:27 AM
BETHESDA, Md., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Sucampo AG ("SAG"), a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), headquartered in Zug, Switzerland, announced today that all physicians in Switzerland are now able to prescribe AMITIZA® (lubiprostone) for chronic idiopathic constipation (CIC), as a result of the revision of the reimbursement limitations by the Bundesamt für Gesundheit (BAG), effective February 1, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by